Electric Vehicle Maker Rivian Prices Upsized US$11.9 Billion IPO

Start-up electric vehicle maker Rivian Automotive, Inc. (Nasdaq: RIVN) started trading on the Nasdaq Global Select Market today while also announcing pricing for their IPO. The firm aims to raise US$11.9 billion in its debut on the big board.

The offering consisted of 153 million Class A common shares at US$78.00 per share, an increase from the initial price range of US$57.00 – US$62.00. The company’s shares will be trading on the Nasdaq exchange under the ticker symbol “RIVN”.

Morgan Stanley, Goldman Sachs & Co., and J.P. Morgan are acting as the lead bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 22.95 million shares at the same IPO price, potentially bringing proceeds up to US$13.7 billion.

The offering is expected to close on November 15, 2021, subject to customary closing conditions.

The electric automaker, backed by Amazon and Ford, previously announced the start of its production, with Amazon announcing in 2019 the purchase of 100,000 vehicles. The pricing puts the company’s valuation to approximately $76.4 billion on a fully diluted basis.


Information for this briefing was found via Edgar, Bloomberg, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

CBS News Cuts Staff and Shuts Radio Network in Early Bari Weiss Era

Related News

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM

Ripple Plans For Public Debut Following SEC Lawsuit Settlement

Despite an ongoing SEC lawsuit, major cryptocurrency company Ripple has not given up on making...

Friday, April 30, 2021, 02:38:00 PM

Holtec IPO Poised At $10B, Could Be Nuclear’s Largest

Holtec International has filed confidentially with the SEC to go public, positioning what could be...

Monday, February 16, 2026, 08:46:00 AM

India-Focused Tech SPAC Cartica Acquisition Prices US$200 Million IPO

Special purpose acquisition company Cartica Acquisition Corp. (Nasdaq: CITEU) started trading on the Nasdaq Global...

Wednesday, January 5, 2022, 02:17:00 PM